Variant Bio is a Seattle-based biotech company entering a rapid growth stage having closed a $105mm Series B financing in the fourth quarter of 2021. The company was started because we believe

COVID VACCINE AND FLU SHOT REQUIRED. Two year AMA accredited School of Radiologic Technology. Previous experience in trauma preferred.